You have 9 free searches left this month | for more free features.

stage%20IV%20chronic%20lymphocytic%20leukemia

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Understanding Chronic Lymphocytic Leukemia

Recruiting
  • Chronic Lymphocytic Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Aug 1, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Pneumococcal 13-valent Conjugate Vaccine
    • Pneumococcal Polyvalent Vaccine
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 10, 2022

    Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • [U-13C]glucose
    • [13C5]glutamine
    • Madison, Wisconsin
      University of Wisconsin
    Jun 15, 2022

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in New York (Ibrutinib, Pembrolizumab)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Mantle Cell Lymphoma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 22, 2022

    Orelabrutinib in the Treatment of CLL/SLL

    Not yet recruiting
    • CLL/SLL
      • (no location specified)
      Jul 26, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary

      Recruiting
      • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +8 more
      • Scottsdale, Arizona
      • +1 more
      May 16, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Dec 19, 2022

      Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • Questionnaires
      • Fit Bit
      • Houston, Texas
        M D Anderson Cancer Center
      May 18, 2023

      Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

      Recruiting
      • Chronic Lymphocytic Leukemia
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 4, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Leukemia
      • Boston, Massachusetts
      • +1 more
      Nov 14, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • High Dose Methylprednisolone (HDMP)
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 12, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Acalabrutinib (Arm A)
      • Acalabrutinib (Arm B)
      • Bethesda, Maryland
        Research Site
      Jan 3, 2023

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Active, not recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Duarte, California
      • +2 more
      Oct 7, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
      • Acalabrutinib capsule
      • Ahmedabad, India
      • +12 more
      Feb 2, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • +3 more
      • Boston, Massachusetts
      • +11 more
      Nov 23, 2022

      Chronic Lymphocytic Leukemia (CLL), Waldenstrom Macroglobulinemia (WM) Trial in Rochester (Shingrix vaccine)

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
      • Waldenstrom Macroglobulinemia (WM)
      • Shingrix vaccine
      • Rochester, New York
        University of Rochester
      Jan 9, 2023

      Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Granada, Spain
        • +4 more
        Nov 8, 2023

        Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

        Active, not recruiting
        • Recurrent Chronic Lymphoid Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Dec 19, 2022